Forefront Analytics LLC purchased a new position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 19,982 shares of the technology company’s stock, valued at approximately $117,000. A number of other large investors have also made changes to their positions in COGT. AJOVista LLC acquired […]